Earnings call transcript: Tilray Q1 2026 sees revenue growth, stock surges

Tilray Inc. reported a strong first quarter for fiscal year 2026, achieving record net revenue of $210 million, a 5% year-over-year increase that surpassed analyst forecasts by 2.4%. The company returned to profitability with a net income of $1.5 million, reversing a significant loss from the prior year, and saw its stock surge 25.92% in pre-market trading. Key drivers included 5% growth in cannabis revenue and 9% in distribution, alongside progress in cost-saving initiatives within its beverage segment, with Tilray reaffirming its FY2026 adjusted EBITDA guidance of $62-72 million and highlighting strategic expansion into international cannabis markets and potential U.S. medical cannabis opportunities.

Analysis

Tilray Inc. reported a strong Q1 FY2026, achieving record net revenue of $210 million, a 5% year-over-year increase that surpassed analyst forecasts by 2.4%. The company returned to profitability with a net income of $1.5 million, reversing a $34.7 million net loss from the prior year. This positive financial turnaround led to a significant 25.92% surge in TLRY's stock price during pre-market trading.

Growth was primarily driven by a 5% increase in cannabis revenue to $64.5 million and a 9% rise in distribution revenue to $74 million. Adjusted EBITDA improved by 9.7% year-over-year to $10.2 million, and the company reaffirmed its FY2026 adjusted EBITDA guidance of $62-72 million. Tilray also strengthened its balance sheet, reducing net debt to $3.9 million and maintaining a $265 million cash position.

Management highlighted strategic expansion into international cannabis markets, particularly Germany and Italy, and anticipates significant opportunities in the U.S. medical cannabis sector, estimating a potential $300-500 million business if rescheduling occurs. The company continues to realize cost savings through "Project Four Twenty" and is diversifying its revenue streams across cannabis, beverage, and wellness segments.

Despite positive momentum, regulatory hurdles in international markets and potential changes in U.S. cannabis regulations remain key risks. Notably, Tilray has invested $1 million in Bitcoin and plans to integrate crypto payments, indicating an exploration of new financial technologies and investor engagement strategies.

Key Decisions for Investors

• Investors should monitor Tilray's execution on international cannabis expansion and the progress of U.S. cannabis rescheduling, as these are significant growth catalysts.
• Evaluate the sustainability of the company's return to profitability and gross margin improvements, particularly within the challenging beverage segment, and track further debt reduction.
• Assess the strategic implications and potential financial impact of Tilray's nascent crypto investment and payment integration plans.
• Consider the reaffirmed FY2026 adjusted EBITDA guidance in light of ongoing regulatory complexities and market saturation in Canadian cannabis.